Hrishikesh Kulkarni

Associate Professor-in-residence, Medicine, University of California Los Angeles

Interests

Immunology, Transplantation, ARDS, Lung injury, Pneumonia, Complement

Education and Training

Washington University School of MedicineResearch Fellowship02/2018Pulmonary Immunology/Host Defense
Washington University School of MedicineMSCI12/2017Translational Research Track
Washington University School of MedicineClinical Fellowship06/2016Pulmonary and Critical Care Medicine
University of Pittsburgh (UPMC)Residency06/2013Internal Medicine
Seth GS Medical College and KEM HospitalMBBS/MD05/2009Medicine

Awards and Honors

  • Elected Member, American Society of Clinical Investigation, 2025.
  • Svar Excellence in Complement Award, International Complement Society, 2023.
  • Early Career Award for Research in Complement, International Complement Society, 2021.
  • Young Physician-Scientist Award, American Society of Clinical Investigation, 2020.
  • Elected Fellow (ATSF), American Thoracic Society, 2019.
  • Recognition of Early Academic Achievement Award, American Thoracic Society, 2019.
  • Elected Fellow (FCCP), American College of Chest Physicians, 2017.
  • Elected Fellow (FACP), American College of Physicians, 2017.

Publications

  1. Shankar NR, Garnica L, Stahlschmidt E, Gelman AE, Byers D, Kulkarni H. Characteristics of Human Donor Lungs Utilized for Research.. American journal of respiratory cell and molecular biology, 2025.
  2. Liao F, Zhou D, Cano M, Liu Z, Scozzi D, Tague LK, Byers DE, Li W, Sivapackiam J, Sharma V, Krupnick AS, Frank DW, Kreisel D, Kulkarni HS, Hachem RR, Gelman AE. Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection.. Science translational medicine, 2025.
  3. Kulkarni HS, Tague LK, Calabrese DR, Liao F, Liu Z, Garnica L, Shankar N, Wu X, Kulkarni DH, Bernardt C, Byers D, Chen C, Huang HJ, Witt CA, Hachem RR, Kreisel D, Atkinson JP, Greenland JR, Gelman AE. Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.. bioRxiv : the preprint server for biology, 2024.
  4. Lehmann M, Krishnan R, Sucre J, Kulkarni HS, Pineda RH, Anderson C, Banovich NE, Behrsing HP, Dean CH, Haak A, Gosens R, Kaminski N, Zagorska A, Koziol-White C, Metcalf JP, Kim YH, Loebel C, Neptune E, Noel A, Raghu G, Sewald K, Sharma A, Suki B, Sperling A, Tatler A, Turner S, Rosas IO, van Ry P, Wille T, Randell SH, Pryhuber G, Rojas M, Bourke J, Königshoff M. Precision Cut Lung Slices: Emerging Tools for Preclinical and Translational Lung Research. An Official American Thoracic Society Workshop Report.. American journal of respiratory cell and molecular biology, 2024.
  5. Earhart AP, Alburquerque RA, Starick M, Nallapu A, Garnica L, Ozanturk AN, Maurya RK, Wu X, Haspel JA, Kulkarni HS. The C3-C3aR axis modulates trained immunity in alveolar macrophages.. bioRxiv : the preprint server for biology, 2024.
  6. Earhart AP, Kulkarni HS. Monocytes: See One Queuing Local Adaptive Immune Responses to Respiratory Viruses.. American journal of respiratory cell and molecular biology, 2024.
  7. Shankar NR, Garnica L, Stahlschmidt E, Byers D, Kulkarni H. Characteristics of human donor lungs utilized for research.. bioRxiv : the preprint server for biology, 2024.
  8. Kulkarni DH, Starick M, Aponte Alburquerque R, Kulkarni HS. Local complement activation and modulation in mucosal immunity.. Mucosal immunology, 2024.
  9. Kulkarni HS. Hexamerization: explaining the original sin of IgG-mediated complement activation in acute lung injury.. The Journal of clinical investigation, 2024.
  10. Sahu SK, Maurya RK, Kulkarni HS. The Role of Complement Component C3 in Protection Against Pseudomonas Pneumonia-Induced Lung Injury.. DNA and cell biology, 2024.
  11. Kulkarni DH, Rusconi B, Floyd AN, Joyce EL, Talati KB, Kousik H, Alleyne D, Harris DL, Garnica L, McDonough R, Bidani SS, Kulkarni HS, Newberry EP, McDonald KG, Newberry RD. Gut microbiota induces weight gain and inflammation in the gut and adipose tissue independent of manipulations in diet, genetics, and immune development.. Gut microbes, 2023.
  12. January SE, Hubbard J, Fester KA, Dubrawka CA, Vazquez Guillamet R, Kulkarni HS, Hachem RR. Impact of Angiotensin Blockade on Development of Chronic Lung Allograft Dysfunction.. Journal of pharmacy practice, 2023.
  13. Moore BB, Ballinger MN, Bauer NN, Blackwell TS, Borok Z, Budinger GRS, Camoretti-Mercado B, Erzurum SC, Himes BE, Keshamouni VG, Kulkarni HS, Mallampalli RK, Mariani TJ, Martinez FJ, McCombs JE, Newcomb DC, Johnston RA, O'Reilly MA, Prakash YS, Ridge KM, Sime PJ, Sperling AI, Violette S, Wilkes DS, Königshoff M. Building Career Paths for Ph.D., Basic and Translational Scientists in Clinical Departments in the United States: An Official American Thoracic Society Workshop Report.. Annals of the American Thoracic Society, 2023.
  14. January SE, Fester KA, Halverson LP, Witt CA, Byers DE, Vazquez-Guillamet R, Alexander-Brett J, Tague LK, Kreisel D, Gelman A, Puri V, Bahena RN, Takahashi T, Hachem RR, Kulkarni HS. Tocilizumab for antibody-mediated rejection treatment in lung transplantation.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2023.
  15. Terada Y, Takahashi T, Hachem RR, Liu J, Witt CA, Byers DE, Guillamet RV, Kulkarni HS, Nava RG, Kozower BD, Meyers BF, Pasque MK, Patterson GA, Marklin GF, Eghtesady P, Kreisel D, Puri V. Characteristics of donor lungs declined on site and impact of lung allocation policy change.. The Journal of thoracic and cardiovascular surgery, 2023.
  16. Annane D, Pittock SJ, Kulkarni HS, Pickering BW, Khoshnevis MR, Siegel JL, Powell CA, Castro P, Fujii T, Dunn D, Smith K, Mitter S, Kazani S, Kulasekararaj A. Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial.. The Lancet. Respiratory medicine, 2023.
  17. Terada Y, Hachem RR, Pasque MK, Kulkarni HS, Witt CA, Byers DE, Guillamet RV, Nava RG, Kozower BD, Meyers BF, Patterson GA, Kreisel D, Puri V, Takahashi T. Pulmonary Carcinoid Tumorlet in the Explanted Lungs for Lung Transplantation: A Case Series of 15 Patients.. Transplantation proceedings, 2023.
  18. Sahu SK, Ozantürk AN, Kulkarni DH, Ma L, Barve RA, Dannull L, Lu A, Starick M, McPhatter J, Garnica L, Sanfillipo-Burchman M, Kunen J, Wu X, Gelman AE, Brody SL, Atkinson JP, Kulkarni HS. Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury.. Science immunology, 2023.
  19. Liu Z, Liao F, Zhu J, Zhou D, Heo GS, Leuhmann HP, Scozzi D, Parks A, Hachem R, Byers DE, Tague LK, Kulkarni HS, Cano M, Wong BW, Li W, Huang HJ, Krupnick AS, Kreisel D, Liu Y, Gelman AE. Reprogramming alveolar macrophage responses to TGF-β reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome.. The Journal of clinical investigation, 2022.
  20. Shepherd HM, Terada Y, Takahashi T, Pasque MK, Kulkarni HS, Guillamet RV, Witt CA, Nava RG, Puri V, Kreisel D, Patterson GA, Hachem RR. Acute Interstitial Pneumonia (Hamman-Rich Syndrome) in Lung Transplantation: A Case Series.. Transplantation proceedings, 2022.
  21. Kulkarni HS, Lee JS, Downey GP, Matute-Bello G. Reply: Experimental Acute Lung Injury in Animals: With Age Comes Knowledge.. American journal of respiratory cell and molecular biology, 2022.
  22. Yang Z, Takahashi T, Terada Y, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Byers DE, Kulkarni HS, Guillamet RV, Yan Y, Chang SH, Kreisel D, Puri V. A comparison of outcomes after lung transplantation between European and North American centers.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2022.
  23. Terada Y, Takahashi T, Hachem RR, Liu J, Witt CA, Byers DE, Guillamet RV, Kulkarni HS, Nava RG, Kozower BD, Meyers BF, Pasque MK, Patterson GA, Kreisel D, Puri V. Clinical features and outcomes of unplanned single lung transplants.. The Journal of thoracic and cardiovascular surgery, 2022.
  24. Kulkarni HS, Lee JS, Bastarache JA, Kuebler WM, Downey GP, Albaiceta GM, Altemeier WA, Artigas A, Bates JHT, Calfee CS, Dela Cruz CS, Dickson RP, Englert JA, Everitt JI, Fessler MB, Gelman AE, Gowdy KM, Groshong SD, Herold S, Homer RJ, Horowitz JC, Hsia CCW, Kurahashi K, Laubach VE, Looney MR, Lucas R, Mangalmurti NS, Manicone AM, Martin TR, Matalon S, Matthay MA, McAuley DF, McGrath-Morrow SA, Mizgerd JP, Montgomery SA, Moore BB, Noël A, Perlman CE, Reilly JP, Schmidt EP, Skerrett SJ, Suber TL, Summers C, Suratt BT, Takata M, Tuder R, Uhlig S, Witzenrath M, Zemans RL, Matute-Bello G. Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report.. American journal of respiratory cell and molecular biology, 2022.
  25. Sahu SK, Kulkarni DH, Ozanturk AN, Ma L, Kulkarni HS. Emerging roles of the complement system in host-pathogen interactions.. Trends in microbiology, 2021.
  26. Tague LK, Bedair B, Witt C, Byers DE, Vazquez-Guillamet R, Kulkarni H, Alexander-Brett J, Nava R, Puri V, Kreisel D, Trulock EP, Gelman A, Hachem RR. Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2021.
  27. Kulkarni HS, Lease ED. Can we decloak how infections drive complications after lung transplantation?. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2021.
  28. . Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.. Science immunology, 2021.
  29. Randhawa SK, Yang Z, Morkan DB, Yan Y, Chang SH, Hachem RR, Witt CA, Byers DE, Kulkarni HS, Guillamet RV, Kozower BD, Nava RG, Meyers BF, Patterson GA, Kreisel D, Puri V. One-Year Survival Worse for Lung Retransplants Relative to Primary Lung Transplants.. The Annals of thoracic surgery, 2021.
  30. Yang Z, Subramanian MP, Yan Y, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Pasque MK, Byers DE, Kulkarni HS, Kreisel D, Itoh A, Puri V. The Impact of Center Volume on Outcomes in Lung Transplantation.. The Annals of thoracic surgery, 2021.
  31. Bery AI, Kulkarni HS, Kreisel D. Editorial: COVID-19 immunology and organ transplantation.. Current opinion in organ transplantation, 2021.
  32. Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.. bioRxiv : the preprint server for biology, 2021.
  33. Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O'Halloran JA, Goss C, Rauseo AM, Liu Z, Sahu SK, Peritore V, Rocco M, Ricci A, Amodeo R, Aimati L, Ibrahim M, Hachem R, Kreisel D, Mudd PA, Kulkarni HS, Gelman AE. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19.. JCI insight, 2021.
  34. Vazquez Guillamet MC, Kulkarni HS, Montes K, Samant M, Shaikh PA, Betthauser K, Mudd PA, Reynolds D, O'Halloran J, Lyons P, McEvoy C, Vazquez Guillamet R. Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker.. Critical care explorations, 2021.
  35. Frye CC, Gauthier JM, Bery A, Gerull WD, Morkan DB, Liu J, Shea Harrison M, Terada Y, Van Zanden JE, Marklin GF, Pasque MK, Nava RG, Meyers BF, Patterson AG, Kozower BD, Hachem R, Byers D, Witt C, Kulkarni H, Kreisel D, Puri V. Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors.. Clinical transplantation, 2020.
  36. Kulkarni HS, Atkinson JP. Targeting complement activation in COVID-19.. Blood, 2020.
  37. Terada Y, Gauthier JM, Pasque MK, Takahashi T, Liu J, Nava RG, Hachem RR, Witt CA, Byers DE, Vazquez Guillamet R, Kozower BD, Meyers BF, Aguilar PR, Kulkarni HS, Patterson GA, Kreisel D, Puri V. Clinical Outcomes of Lung Transplants From Donors With Unexpected Pulmonary Embolism.. The Annals of thoracic surgery, 2020.
  38. Yang Z, Takahashi T, Gerull WD, Hamilton C, Subramanian MP, Liu J, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Aguilar PR, Pasque MK, Byers DE, Kulkarni HS, Kreisel D, Puri V. Impact of Nighttime Lung Transplantation on Outcomes and Costs.. The Annals of thoracic surgery, 2020.
  39. Kulkarni HS, Ramphal K, Ma L, Brown M, Oyster M, Speckhart KN, Takahashi T, Byers DE, Porteous MK, Kalman L, Hachem RR, Rushefski M, McPhatter J, Cano M, Kreisel D, Scavuzzo M, Mittler B, Cantu E, Pilely K, Garred P, Christie JD, Atkinson JP, Gelman AE, Diamond JM. Local complement activation is associated with primary graft dysfunction after lung transplantation.. JCI insight, 2020.
  40. Gerull WD, Yang Z, Kreisel D, Nava R, Meyers BF, Patterson GA, Kozower BD, Hachem RR, Witt C, Byers D, Kulkarni H, Guillamet RV, Marklin G, Puri V. Local versus distant lung donor procurement does not influence short-term clinical outcomes.. The Journal of thoracic and cardiovascular surgery, 2020.
  41. Frye CC, Bery AI, Kreisel D, Kulkarni HS. Sterile inflammation in thoracic transplantation.. Cellular and molecular life sciences : CMLS, 2020.
  42. Java A, Apicelli AJ, Liszewski MK, Coler-Reilly A, Atkinson JP, Kim AH, Kulkarni HS. The complement system in COVID-19: friend and foe?. JCI insight, 2020.
  43. Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O'Halloran JA, Goss C, Rauseo AM, Liu Z, Peritore V, Rocco M, Ricci A, Amodeo R, Aimati L, Ibrahim M, Hachem R, Kreisel D, Mudd PA, Kulkarni HS, Gelman AE. Circulating Mitochondrial DNA is an Early Indicator of Severe Illness and Mortality from COVID-19.. bioRxiv : the preprint server for biology, 2020.
  44. Bain W, Li H, van der Geest R, Moore SR, Olonisakin TF, Ahn B, Papke E, Moghbeli K, DeSensi R, Rapport S, Saul M, Hulver M, Xiong Z, Mallampalli RK, Ray P, Morris A, Ma L, Doi Y, Zhang Y, Kitsios GD, Kulkarni HS, McVerry BJ, Ferreira VP, Nouraie M, Lee JS. Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.. American journal of respiratory and critical care medicine, 2020.
  45. Kulkarni HS, Scozzi D, Gelman AE. Recent advances into the role of pattern recognition receptors in transplantation.. Cellular immunology, 2020.
  46. Kulkarni HS, Tsui K, Sunder S, Ganninger A, Tague LK, Witt CA, Byers DE, Trulock EP, Nava R, Puri V, Kreisel D, Mohanakumar T, Gelman AE, Hachem RR. Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019.
  47. January SE, Fester KA, Bain KB, Kulkarni HS, Witt CA, Byers DE, Alexander-Brett J, Trulock EP, Hachem RR. Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction.. Clinical transplantation, 2019.
  48. Kulkarni HS, Korenblat KM, Kreisel D. Expanding the donor pool for lung transplantation using HCV-positive donors.. Journal of thoracic disease, 2019.
  49. Tague LK, Witt CA, Byers DE, Yusen RD, Aguilar PR, Kulkarni HS, Bain KB, Fester KA, Puri V, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR. Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States.. Annals of the American Thoracic Society, 2019.
  50. Tague LK, Byers DE, Hachem R, Kreisel D, Krupnick AS, Kulkarni HS, Chen C, Huang HJ, Gelman A. Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.. The pharmacogenomics journal, 2019.
  51. Elvington M, Liszewski MK, Liszewski AR, Kulkarni HS, Hachem RR, Mohanakumar T, Kim AHJ, Atkinson JP. Development and Optimization of an ELISA to Quantitate C3(H 2 O) as a Marker of Human Disease.. Frontiers in immunology, 2019.
  52. Kulkarni H, Parthasarathy S. Is positive airway pressure therapy underutilized in chronic obstructive pulmonary disease patients?. Expert review of respiratory medicine, 2019.
  53. Kulkarni HS, Elvington ML, Perng YC, Liszewski MK, Byers DE, Farkouh C, Yusen RD, Lenschow DJ, Brody SL, Atkinson JP. Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.. American journal of respiratory cell and molecular biology, 2019.
  54. Scozzi D, Ibrahim M, Liao F, Lin X, Hsiao HM, Hachem R, Tague LK, Ricci A, Kulkarni HS, Huang HJ, Sugimoto S, Krupnick AS, Kreisel D, Gelman AE. Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction.. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2019.
  55. Kulkarni HS, Diamond JM, Schrepfer S, Cantu E. Exosomal profiling in cardiac allograft rejection: Best basic science article in 2018.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2018.
  56. Kulkarni HS, Cherikh WS, Chambers DC, Garcia VC, Hachem RR, Kreisel D, Puri V, Kozower BD, Byers DE, Witt CA, Alexander-Brett J, Aguilar PR, Tague LK, Furuya Y, Patterson GA, Trulock EP, Yusen RD. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2018.
  57. Kulkarni HS, Liszewski MK, Brody SL, Atkinson JP. The complement system in the airway epithelium: An overlooked host defense mechanism and therapeutic target?. The Journal of allergy and clinical immunology, 2018.
  58. Kulkarni HS, Witt CA. Voriconazole in lung transplant recipients - how worried should we be?. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2017.
  59. Elvington M, Liszewski MK, Bertram P, Kulkarni HS, Atkinson JP. A C3(H20) recycling pathway is a component of the intracellular complement system.. The Journal of clinical investigation, 2017.
  60. Liszewski MK, Elvington M, Kulkarni HS, Atkinson JP. Complement's hidden arsenal: New insights and novel functions inside the cell.. Molecular immunology, 2017.
  61. Crouch R, Kulkarni HS. Pulmonary Exercise Training before and after Lung Transplantation.. American journal of respiratory and critical care medicine, 2016.
  62. Slatore CG, Kulkarni HS, Corn J, Sockrider M. Improving Health Literacy. The New American Thoracic Society Guidelines for Patient Education Materials.. Annals of the American Thoracic Society, 2016.
  63. Kulkarni HS, Bemiss BC, Hachem RR. Antibody-mediated Rejection in Lung Transplantation.. Current transplantation reports, 2015.
  64. Kulkarni HS, Chey WD, Mookherjee S, Saint S, Bump GM. Taking the detour.. Journal of hospital medicine, 2015.
  65. Kulkarni HS, Gutierrez FR, Despotovic V, Russell TD. A 43-year-old man with antisynthetase syndrome presenting with acute worsening of dyspnea.. Chest, 2015.
  66. Kulkarni HS, Rosenbluth DB. Cavitary lung nodules in a patient with prior squamous cell carcinoma of the submandibular gland.. American journal of respiratory and critical care medicine, 2014.
  67. Kulkarni HS, Khoury CC. Sepsis associated with Lactobacillus bacteremia in a patient with ischemic colitis.. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2014.
  68. Kulkarni HS, Guzy RD, McEvoy C. YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.. American journal of respiratory and critical care medicine, 2014.
  69. Nigwekar SU, Kulkarni H, Thakar CV. Natriuretic peptides in the management of solid organ transplantation associated acute kidney injury: a systematic review and meta-analysis.. International journal of nephrology, 2013.
  70. Chandra D, Wise RA, Kulkarni HS, Benzo RP, Criner G, Make B, Slivka WA, Ries AL, Reilly JJ, Martinez FJ, Sciurba FC, NETT Research Group. Optimizing the 6-min walk test as a measure of exercise capacity in COPD.. Chest, 2012.
  71. Kasi PM, Tawbi HA, Oddis CV, Kulkarni HS. Clinical review: Serious adverse events associated with the use of rituximab - a critical care perspective.. Critical care (London, England), 2012.
  72. Naik C, Kulkarni H, Darabi A, Bhanot N. Ochrobactrum anthropi: a rare cause of pneumonia.. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012.
  73. Kulkarni HS, Kasi PM. Rituximab and cytokine release syndrome.. Case reports in oncology, 2012.
  74. Chandra D, Kulkarni HS, Sciurba F. Learning from the learning effect in the six-minute-walk test.. American journal of respiratory and critical care medicine, 2012.
  75. Kulkarni HS, Chandra D, Sciurba FC. Increase in walk distance is not enough evidence to add a walk to the 6-minute walk test.. The European respiratory journal, 2011.
  76. Kulkarni HS, Kulkarni KR, Mallampalli A, Parkar SR, Karnad DR, Guntupalli KK. Comparison of anxiety, depression, and post-traumatic stress symptoms in relatives of ICU patients in an American and an Indian public hospital.. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2011.
  77. Shin HS, Xu F, Bagchi A, Herrup E, Prakash A, Valentine C, Kulkarni H, Wilhelmsen K, Warren S, Hellman J. Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo.. Journal of immunology (Baltimore, Md. : 1950), 2010.
  78. Kulkarni HS. Less-obvious predictors of post-ICU informal caregiver burden.. Chest, 2010.
  79. Luo X, Zhou Y, Tao D, Yu Y, Hu J, Qiu F, Kulkarni H, Gong J. Usefulness of oral mucosal epithelial cell apoptosis rate in nutritional assessment.. Nutrition (Burbank, Los Angeles County, Calif.), 2006.
  80. Sideris EB, Walsh KP, Haddad JL, Chen CR, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. "Buttoned device" Clinical Trials International Register.. Heart (British Cardiac Society), 1997.
  81. Taskar VS, Rupwate RU, Kulkarni H, Kamat SR. Effect of 3 week oxygen therapy on functional and haemodynamic parameters in chronic obstructive pulmonary disease.. The Journal of the Association of Physicians of India, 1990.